Found 2 hits Enz. Inhib. hit(s) with Target = 'Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform' and Ligand = 'BDBM50119619' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119619
(CHEMBL3618243)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCN(CC2)C(=O)N(C)C)cc1F Show InChI InChI=1S/C185H312N50O53/c1-26-30-48-108(205-152(259)109(49-34-39-72-186)206-157(264)114(54-44-77-200-182(194)195)212-171(278)128(83-98(13)14)230-180(287)184(24,89-99(15)16)234-176(283)130(85-107-91-198-93-202-107)227-172(279)129(84-106-46-32-31-33-47-106)226-175(282)134(92-236)229-170(277)127(82-97(11)12)225-174(281)132(87-144(252)253)204-105(23)237)165(272)231-147(102(20)28-3)179(286)220-123(63-71-143(250)251)166(273)232-148(103(21)29-4)178(285)219-122(62-70-142(248)249)164(271)209-110(50-35-40-73-187)154(261)213-116(56-64-135(190)238)160(267)218-120(60-68-140(244)245)162(269)208-111(51-36-41-74-188)155(262)216-119(59-67-139(242)243)161(268)207-112(52-37-42-75-189)156(263)217-121(61-69-141(246)247)163(270)214-117(57-65-136(191)239)159(266)215-118-58-66-138(241)199-76-43-38-53-113(211-173(280)131(86-137(192)240)221-150(257)104(22)203-151(118)258)153(260)210-115(55-45-78-201-183(196)197)158(265)222-124(79-94(5)6)167(274)223-125(80-95(7)8)168(275)224-126(81-96(9)10)169(276)228-133(88-145(254)255)177(284)235-185(25,90-100(17)18)181(288)233-146(149(193)256)101(19)27-2/h31-33,46-47,91,93-104,108-134,146-148,236H,26-30,34-45,48-90,92,186-189H2,1-25H3,(H2,190,238)(H2,191,239)(H2,192,240)(H2,193,256)(H,198,202)(H,199,241)(H,203,258)(H,204,237)(H,205,259)(H,206,264)(H,207,268)(H,208,269)(H,209,271)(H,210,260)(H,211,280)(H,212,278)(H,213,261)(H,214,270)(H,215,266)(H,216,262)(H,217,263)(H,218,267)(H,219,285)(H,220,286)(H,221,257)(H,222,265)(H,223,274)(H,224,275)(H,225,281)(H,226,282)(H,227,279)(H,228,276)(H,229,277)(H,230,287)(H,231,272)(H,232,273)(H,233,288)(H,234,283)(H,235,284)(H,242,243)(H,244,245)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,254,255)(H4,194,195,200)(H4,196,197,201)/t101?,102?,103?,104-,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118?,119+,120+,121+,122+,123+,124+,125+,126+,127+,128+,129-,130+,131+,132+,133+,134+,146-,147+,148+,184-,185-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 6.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha (unknown origin) by alpha screen assay |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50119619
(CHEMBL3618243)Show SMILES COc1ncc(Nc2nc3ccc(cn3c2-c2nc(C)nc(N)n2)N2CCN(CC2)C(=O)N(C)C)cc1F Show InChI InChI=1S/C185H312N50O53/c1-26-30-48-108(205-152(259)109(49-34-39-72-186)206-157(264)114(54-44-77-200-182(194)195)212-171(278)128(83-98(13)14)230-180(287)184(24,89-99(15)16)234-176(283)130(85-107-91-198-93-202-107)227-172(279)129(84-106-46-32-31-33-47-106)226-175(282)134(92-236)229-170(277)127(82-97(11)12)225-174(281)132(87-144(252)253)204-105(23)237)165(272)231-147(102(20)28-3)179(286)220-123(63-71-143(250)251)166(273)232-148(103(21)29-4)178(285)219-122(62-70-142(248)249)164(271)209-110(50-35-40-73-187)154(261)213-116(56-64-135(190)238)160(267)218-120(60-68-140(244)245)162(269)208-111(51-36-41-74-188)155(262)216-119(59-67-139(242)243)161(268)207-112(52-37-42-75-189)156(263)217-121(61-69-141(246)247)163(270)214-117(57-65-136(191)239)159(266)215-118-58-66-138(241)199-76-43-38-53-113(211-173(280)131(86-137(192)240)221-150(257)104(22)203-151(118)258)153(260)210-115(55-45-78-201-183(196)197)158(265)222-124(79-94(5)6)167(274)223-125(80-95(7)8)168(275)224-126(81-96(9)10)169(276)228-133(88-145(254)255)177(284)235-185(25,90-100(17)18)181(288)233-146(149(193)256)101(19)27-2/h31-33,46-47,91,93-104,108-134,146-148,236H,26-30,34-45,48-90,92,186-189H2,1-25H3,(H2,190,238)(H2,191,239)(H2,192,240)(H2,193,256)(H,198,202)(H,199,241)(H,203,258)(H,204,237)(H,205,259)(H,206,264)(H,207,268)(H,208,269)(H,209,271)(H,210,260)(H,211,280)(H,212,278)(H,213,261)(H,214,270)(H,215,266)(H,216,262)(H,217,263)(H,218,267)(H,219,285)(H,220,286)(H,221,257)(H,222,265)(H,223,274)(H,224,275)(H,225,281)(H,226,282)(H,227,279)(H,228,276)(H,229,277)(H,230,287)(H,231,272)(H,232,273)(H,233,288)(H,234,283)(H,235,284)(H,242,243)(H,244,245)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,254,255)(H4,194,195,200)(H4,196,197,201)/t101?,102?,103?,104-,108+,109+,110+,111+,112+,113+,114+,115+,116+,117+,118?,119+,120+,121+,122+,123+,124+,125+,126+,127+,128+,129-,130+,131+,132+,133+,134+,146-,147+,148+,184-,185-/m1/s1 | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen Inc.
Curated by ChEMBL
| Assay Description
Inhibition of PI3Kalpha in human U87MG cells assessed as reduction in AKT Ser473 phosphorylation incubated for 2 hrs followed by compound wahout by a... |
Bioorg Med Chem Lett 25: 4136-42 (2015)
Article DOI: 10.1016/j.bmcl.2015.08.016
BindingDB Entry DOI: 10.7270/Q2R49SKC |
More data for this
Ligand-Target Pair | |
Search and Browse
